Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
Sarah McNamee, Neşe Devenot, Meaghan Buisson
JAMA Psychiatry (2023) Vol. 80, Iss. 5, pp. 411-411
Closed Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Single-Dose Psilocybin Treatment for Major Depressive Disorder
Charles L. Raison, Gerard Sanacora, Joshua D. Woolley, et al.
JAMA (2023) Vol. 330, Iss. 9, pp. 843-843
Open Access | Times Cited: 237
Must Psilocybin Always “Assist Psychotherapy”?
Guy M. Goodwin, Ekaterina Malievskaia, Gregory A. Fonzo, et al.
American Journal of Psychiatry (2023) Vol. 181, Iss. 1, pp. 20-25
Closed Access | Times Cited: 100
Extended difficulties following the use of psychedelic drugs: A mixed methods study
Jules Evans, Oliver Robinson, Eirini K. Argyri, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293349-e0293349
Open Access | Times Cited: 66
History repeating: guidelines to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 55
Adverse Events in Studies of Classic Psychedelics
Jared T. Hinkle, Marianna Graziosi, Sandeep M. Nayak, et al.
JAMA Psychiatry (2024)
Closed Access | Times Cited: 24
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism
Katherine Cheung, Brian D. Earp, Kyle Patch, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 16-28
Closed Access | Times Cited: 14
MDMA and MDMA-Assisted Therapy
Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 79-103
Closed Access | Times Cited: 6
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
History repeating: A roadmap to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
(2023)
Open Access | Times Cited: 23
Is Poorly Assisted Psilocybin Treatment an Increasing Risk?
Eduardo Ekman Schenberg, Franklin King, João Eusébio da Fonseca, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 75-76
Closed Access | Times Cited: 13
A framework for assessment of adverse events occurring in psychedelic-assisted therapies
Roman Palitsky, Deanna M. Kaplan, John Perna, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 690-700
Closed Access | Times Cited: 13
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
Amy L. McGuire, I. Glenn Cohen, Dominic A. Sisti, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2414650-e2414650
Open Access | Times Cited: 12
Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA
Abigail E. Calder, Gregor Hasler
Journal of Affective Disorders (2024) Vol. 365, pp. 258-264
Open Access | Times Cited: 10
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 9
Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis
Julia Colcott, Alexandre Guerin, Olivia Carter, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 8, pp. 1208-1226
Open Access | Times Cited: 8
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research
Kelley C. O’Donnell, Jim Grigsby, Charles S. Grob
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 13-16
Closed Access | Times Cited: 1
What is Psychological Support in the Context of Psychedelic Clinical Trials?
Jérémie Richard, Michael Levine
Psychedelic Medicine (2025)
Closed Access | Times Cited: 1
Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report
John Perna, Justin Trop, Roman Palitsky, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions
Bill Brennan, Alex R. Kelman, Alexander B. Belser
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 218-229
Open Access | Times Cited: 21
Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences
Eirini K. Argyri, Jules Evans, David Luke, et al.
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 8
Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations
Andrew G. Lee, Daniel Rosenbaum, Daniel Z. Buchman
The Canadian Journal of Psychiatry (2024) Vol. 69, Iss. 5, pp. 309-313
Open Access | Times Cited: 7
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary
Michael D. Alpert, Kelley C. O’Donnell, Casey A. Paleos, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 76-77
Closed Access | Times Cited: 6
Spiritual health practitioners’ contributions to psychedelic assisted therapy: A qualitative analysis
Caroline Peacock, Jennifer S. Mascaro, Erin Brauer, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296071-e0296071
Open Access | Times Cited: 6
Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers
Kevin F. Boehnke, Kasey Cox, Cody Weston, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top